[96a5a0]: / output / chiaCancer / identified / NCT01768195_identified.json

Download this file

164 lines (164 with data), 5.6 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
{
"info": {
"nct_id": "NCT01768195",
"official_title": "Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy",
"inclusion_criteria": "* treatment-naive patients with B-cell lymphoma\n* HBsAg positive at baseline\n* treated with rituximab-based immunochemotherapy\n* life expectancy of more than 3 months\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* younger than 18 years old\n* HBsAg negative at baseline\n* pregnant or lactating women",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* treatment-naive patients with B-cell lymphoma",
"criterions": [
{
"exact_snippets": [
"treatment-naive"
],
"criterion": "treatment status",
"requirement_type": "status",
"expected_value": "naive"
},
{
"exact_snippets": [
"B-cell lymphoma"
],
"criterion": "B-cell lymphoma",
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"line": "* HBsAg positive at baseline",
"criterions": [
{
"exact_snippets": [
"HBsAg positive"
],
"criterion": "HBsAg",
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"line": "* treated with rituximab-based immunochemotherapy",
"criterions": [
{
"exact_snippets": [
"treated with rituximab-based immunochemotherapy"
],
"criterion": "rituximab-based immunochemotherapy",
"requirement_type": "treatment",
"expected_value": true
}
]
},
{
"line": "* life expectancy of more than 3 months",
"criterions": [
{
"exact_snippets": [
"life expectancy",
"more than 3 months"
],
"criterion": "life expectancy",
"requirement_type": "duration",
"expected_value": {
"operator": ">",
"value": 3
}
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": [
"Healthy volunteers allowed"
],
"criterion": "healthy volunteers",
"requirement_type": "participation",
"expected_value": true
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": [
"minimum age of 18 Years"
],
"criterion": "age",
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18
}
}
]
}
],
"exclusion_lines": [
{
"line": "* younger than 18 years old",
"criterions": [
{
"exact_snippets": [
"younger than 18 years old"
],
"criterion": "age",
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": "<",
"value": 18
}
]
}
}
]
},
{
"line": "* HBsAg negative at baseline",
"criterions": [
{
"exact_snippets": [
"HBsAg negative"
],
"criterion": "HBsAg",
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"line": "* pregnant or lactating women",
"criterions": [
{
"exact_snippets": [
"pregnant"
],
"criterion": "pregnancy",
"requirement_type": "status",
"expected_value": true
},
{
"exact_snippets": [
"lactating"
],
"criterion": "lactation",
"requirement_type": "status",
"expected_value": true
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}